Partners Karen Lent and Kenneth Schwartz discuss two recent steps enforcement agencies have taken to address competition in the pharmaceutical industry — the recently announced multijurisdictional Working Group and the 6(b) Order issued to six health insurance companies by the FTC.
Health Care Remains a Key FTC Focus
New York Law Journal